Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Evidence-Based Treatment Options for the Management of Skin Toxicities Associated with Epidermal Growth Factor Receptor Inhibitors
Annals of Pharmacotherapy, 09/23/09
Tan EH et al. – Overall, antibiotics are the most common treatment option and have the potential to reduce the severity of skin rash. Well–designed clinical studies with proper recording of relevant data on the management of EGFRI–induced dermatologic effects are needed to properly evaluate the use of various therapeutic agents.
Related Articles
Physiological skin conditions of preterm and term neonates
Clinical and Experimental Dermatology, 10/05/09
Relevance Score: 94%
Age-dependent changes in skin surface assessed by a novel two-dimensional image analysis
Skin Research and Technology, 10/27/09
Relevance Score: 91%
Effectiveness of skin protection measures in prevention of occupational hand eczema: results of a prospective randomized controlled trial over a follow-up period of 1 year
British Journal of Dermatology, 10/14/09
Relevance Score: 91%
Analysis of Translucency of Skin by Volume Reflection for Color Formulation of Facial Prostheses
The International Journal of Prosthodontics, 11/20/09
Relevance Score: 90%
Changes in Skin Tanning Attitudes: Fashion Articles and Advertisements in the Early 20th Century
American Journal of Public Health, 10/28/09
Relevance Score: 90%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders
Journal of Dermatological Treatment , 12/04/09
Non-psoriatic dermatologic uses of monoclonal antibody therapy
Journal of Dermatological Treatment , 12/04/09
Does Simvastatin Cause More Myotoxicity Compared with Other Statins
Annals of Pharmacotherapy, 12/03/09
Sponsor
Article Search
Sponsor


See Latest Articles


